Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Lack of Oncogenic Effect of the H-Viruses for Hamsters

Abstract

BECAUSE the H1 and RV2 viruses are somewhat similar in size to members of the oncogenic papova group, there has been considerable speculation about whether they, too, might have an oncogenic property. Toolan1 first reported that H-1 virus had not produced tumours in a small group of aged “mongoloid-type” hamsters injected at birth with H-1. Later, Kilham and Maloney3 noted that neoplasms had not been found in any of the species inoculated with RV when newborn, except for a few benign odontogenic tumours.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Toolan, H. W., Bull. N.Y. Acad. Sci., 37, 305 (1961).

    CAS  Google Scholar 

  2. Kilham, L., Virology, 13, 141 (1961).

    Article  CAS  Google Scholar 

  3. Kilham, L., and Maloney, J. B., J. Nat. Cancer Inst., 32, 523 (1964).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

TOOLAN, H. Lack of Oncogenic Effect of the H-Viruses for Hamsters. Nature 214, 1036 (1967). https://doi.org/10.1038/2141036a0

Download citation

  • Received:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/2141036a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing